These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31235175)

  • 41. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
    Ou HT; Chang KC; Li CY; Yang CY; Ko NY
    Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dyslipidaemia in adults with type 1 diabetes-when to treat?
    Lan NSR; Fegan PG; Yeap BB; Bell DA; Watts GF
    Diabetes Metab Res Rev; 2019 Jan; 35(1):e3090. PubMed ID: 30339719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
    De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P
    Infection; 2016 Oct; 44(5):589-97. PubMed ID: 27048184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.
    Hero C; Rawshani A; Svensson AM; Franzén S; Eliasson B; Eeg-Olofsson K; Gudbjörnsdottir S
    Diabetes Care; 2016 Jun; 39(6):996-1003. PubMed ID: 27208327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.
    Gumbs PD; Verschuren WM; Mantel-Teeuwisse AK; de Wit AG; Hofman A; Trienekens PH; Stricker BH; de Boer A; Klungel OH
    Drugs Aging; 2006; 23(9):733-41. PubMed ID: 17020397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
    de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
    Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
    Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
    Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
    Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; Pétursson H
    J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction and early detection of cardiovascular disease in South Asians with diabetes mellitus.
    Wander GS; Bansal M; Kasliwal RR
    Diabetes Metab Syndr; 2020; 14(4):385-393. PubMed ID: 32334394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of non-treatment with statins of high risk patients in The Netherlands.
    van den Haak P; Heintjes E; Plat AW; Jan Meerding W; Webb K; Sturkenboom MC; Herings RM
    Curr Med Res Opin; 2010 Feb; 26(2):271-8. PubMed ID: 19929592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice.
    Keller H; Krones T; Becker A; Hirsch O; Sönnichsen AC; Popert U; Kaufmann-Kolle P; Rochon J; Wegscheider K; Baum E; Donner-Banzhoff N
    Eur J Prev Cardiol; 2012 Jun; 19(3):322-9. PubMed ID: 21450565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.
    Gordin D; Forsblom C; Panduru NM; Thomas MC; Bjerre M; Soro-Paavonen A; Tolonen N; Sandholm N; Flyvbjerg A; Harjutsalo V; Groop PH;
    Diabetes Care; 2014 Sep; 37(9):2593-600. PubMed ID: 24969575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.